Haemodialysis – CKD-MBD/Anaemia/Adequacy

V KAREPALLI1,  A ABEYARATNE1, M MOGULLA1, K PRIYADARSHANA1 1Royal Darwin Hospital, Nightcliff, Australia Aim: To evaluate the effect of Cinacalcet cessation on biochemical markers and rates of Parathyroidectomy in Topend of Northern Territory. Background: Secondary hyperparathyroidism is a well-known complication...
SY WIBISONO1 1Rsud Ketapang, Ketapang, Indonesia Background. Erythropoietin (ESA) resistance are common in patients who undergo regular hemodialysis, and most of them caused by the inflammatory process. Poor in oral hygiene is one source of inflammation in patients undergoing regular...
RA MUZASTI1,2, N LUBIS2,  HR LUBIS1 1University of Sumatera Utara, Medan, Indonesia, 2Adam Malik Hospital, Medan, Indonesia Background: Fibroblast growth factor 23 (FGF23) is an important hormone in the regulation of phosphate metabolism.The relationship between FGF23 and vascular calcification is...
A KRISHNAN1, J LEWIS2, G WONG4,5,6,7, R PRINCE1,3, W LIM1,7 1Sir Charles Gairdner Hospital, Perth, Australia, 2Edith Cowan University, Perth, Australia, 3University of Western Australia, Perth, Australia, 4Centre for Renal and Transplant Research, Westmead Hospital, Sydney, Australia, 5Centre for Kidney...
J GAUTIER1, L HIGNELL3, H JONES1, E WEINHANDL2 1NxStage Medical Inc, Lawrence, United States, 2University of Minnesota, College of Pharmacy, Minneapolis, United States, 3NxStage Medical UK Ltd, Amersham, United Kingdom Purpose: In Australia, 13% of haemodialysis patients dialyze at home,...
M RUDIANSYAH1,5,R ROESLI2, A MARTAKUSUMAH2, R SUPRIYADI2, D RACHMADI3, R BANDIARA2, L LUBIS4 1Division of Nephrology & Hypertension, Department of Internal Medicine  Faculty of Medicine University of Lambung Mangkurat / Ulin General Hospital, Banjarmasin, Indonesia, 2Division of Nephrology & Hypertension,...
I RUDERMAN1,2, E SMITH1,2, N TOUSSAINT1,2,T HEWITSON1,2, S HOLT1,2 1The Royal Melbourne Hospital, Parkville, Australia, 2The University of Melbourne, Parkville, Australia Aim: To assess changes in novel biochemical biomarkers, calciprotein particles following cessation of cinacalcet in dialysis patients. Background: The...
P LEUNG1, D LANGSFORD1, 2 1Department of Nephrology, Northern Health, Melbourne, Victoria; 2University of Melbourne, Melbourne Aim: To determine whether a new protocol results in improved iron stores, haemoglobin stability and reduced erythropoietin-stimulating agents (ESA) use. Background: It is recognised that...
YS RAJARAM1, H DIXON 2, C MCBRIDE3, H GOCK1, 3 1Department of Nephrology; 2Pharmacy Department; 3Department of Medicine, University of Melbourne, St Vincent’s Hospital Melbourne, AUSTRALIA. Background: Cinacalcet, a patented calcimimetic was PBS-listed 2008-2015 to treat secondary hyperparathyroidism (hPTH) in...
CW NG1, SD YAP2, R RAJ3, M MATHEW3 1Peninsula Health, Frankston, Victoria; 2Alfred Health, Melbourne, Victoria; 3Launceston General Hospital, Launceston, Tasmania Aim: This study investigated cholecalciferol’s efficacy in maintaining serum calcium in adult dialysis dependent chronic kidney disease patients. Background: Dialysis dependent...
Recent Comments
    Categories